$OKE
ONEOK INC /NEW/ Stock $oke

$oke Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000103968424000015 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$4.781B	$5.235B	$17.68B
YoY Change	5.75%	4.03%	-21.04%
Cost Of Revenue	$2.897B	$3.301B	$11.93B
YoY Change	-13.44%	-15.21%	-33.39%
Gross Profit	$1.884B	$1.934B	$5.748B
YoY Change	60.48%	69.83%	28.39%
Gross Profit Margin	39.41%	36.94%	32.52%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$254.0M	$260.0M	$769.0M
YoY Change	56.79%	65.17%	22.82%
% of Gross Profit	13.48%	13.44%	13.38%
Operating Expenses	$820.0M	$810.0M	$1.518B
YoY Change	79.04%	68.91%	-14.52%
Operating Profit	$1.064B	$1.124B	$4.072B
YoY Change	-28.92%	70.5%	45.04%
Interest Expense	$300.0M	-$235.0M	$866.0M
YoY Change	80.72%	81.28%	28.12%
% of Operating Profit	28.2%	-20.91%	21.27%
Other Income/Expense, Net	$7.000M	$46.00M	$89.00M
YoY Change	-12.5%	-4906.69%	-377.27%
Pretax Income	$847.0M	$910.0M	$3.497B
YoY Change	-38.58%	45.12%	55.45%
Income Tax	$208.0M	$222.0M	$838.0M
% Of Pretax Income	24.56%	24.4%	23.96%
Net Earnings	$639.0M	$688.0M	$2.659B
YoY Change	-39.08%	41.96%	54.39%
Net Earnings / Revenue	13.37%	13.14%	15.04%
Basic Earnings Per Share	$1.09		$5.49
Diluted Earnings Per Share	$1.09	$1.18	$5.48
COMMON SHARES
Basic Shares Outstanding	583.2M shares	582.6M shares	484.3M shares
Diluted Shares Outstanding	585.7M shares		485.4M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.00M	$338.0M	$338.0M
YoY Change	-90.44%	53.48%	53.48%
Cash & Equivalents	$65.00M	$338.0M	$338.0M
Short-Term Investments
Other Short-Term Assets	$212.0M	$252.0M	$252.0M
YoY Change	34.18%	46.9%	46.9%
Inventory	$798.0M	$639.0M	$813.0M
Prepaid Expenses
Receivables	$1.699B	$1.705B	$1.705B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.950B	$3.108B	$3.108B
YoY Change	14.83%	21.99%	21.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.81B	$32.70B	$32.70B
YoY Change	63.71%	63.87%	63.2%
Goodwill	$5.056B	$4.952B
YoY Change		838.6%
Intangibles	$1.311B	$1.316B
YoY Change		484.17%
Long-Term Investments	$1.939B	$1.874B	$1.874B
YoY Change	145.75%	133.73%	133.73%
Other Assets	$327.0M	$319.0M	$319.0M
YoY Change	3.48%	-1.58%	32.2%
Total Long-Term Assets	$41.44B	$41.16B	$41.16B
YoY Change	89.27%	88.53%	88.53%
TOTAL ASSETS
Total Short-Term Assets	$2.950B	$3.108B	$3.108B
Total Long-Term Assets	$41.44B	$41.16B	$41.16B
Total Assets	$44.39B	$44.27B	$44.27B
YoY Change	81.45%	81.57%	81.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.480B	$1.564B	$1.564B
YoY Change	37.8%	15.04%	15.04%
Accrued Expenses	$268.0M	$404.0M	$404.0M
YoY Change	79.87%	64.67%	64.67%
Deferred Revenue	$99.00M	$104.0M
YoY Change		346.35%
Short-Term Debt	$320.0M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.200B	$484.0M	$484.0M
YoY Change	140.0%	-47.68%	-47.84%
Total Short-Term Liabilities	$4.194B	$3.452B	$3.452B
YoY Change	92.21%	13.12%	13.12%
LONG-TERM LIABILITIES
Long-Term Debt	$20.45B	$21.18B	$21.18B
YoY Change	60.65%	66.85%	66.6%
Other Long-Term Liabilities	$559.0M	$479.0M	$553.0M
YoY Change	69.91%	44.66%	45.56%
Total Long-Term Liabilities	$21.01B	$21.66B	$21.74B
YoY Change	60.88%	66.29%	65.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.194B	$3.452B	$3.452B
Total Long-Term Liabilities	$21.01B	$21.66B	$21.74B
Total Liabilities	$25.20B	$25.11B	$27.78B
YoY Change	65.37%	56.2%	55.34%
SHAREHOLDERS EQUITY
Retained Earnings	$927.0M	$868.0M
YoY Change	37.95%	1622.36%
Common Stock	$6.000M	$6.000M
YoY Change	20.0%	26.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$663.0M	$677.0M
YoY Change	-5.15%	-4.13%
Treasury Stock Shares
Shareholders Equity	$16.45B	$16.48B	$16.48B
YoY Change
Total Liabilities & Shareholders Equity	$44.39B	$44.27B	$44.27B
YoY Change	81.45%	81.57%	81.57%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$639.0M	$688.0M	$2.659B
YoY Change	-39.08%	41.96%	54.39%
Depreciation, Depletion And Amortization	$254.0M	$260.0M	$769.0M
YoY Change	56.79%	65.17%	22.82%
Cash From Operating Activities	$596.0M	$1.508B	$4.421B
YoY Change	-51.19%	44.94%	52.14%
INVESTING ACTIVITIES
Capital Expenditures	$512.0M	$603.0M	$1.595B
YoY Change	77.16%	90.81%	32.69%
Acquisitions			$5.015B
YoY Change
Other Investing Activities	-$1.000M	-$42.00M	-$35.00M
YoY Change		-203.36%	-17.75%
Cash From Investing Activities	-$578.0M	-$645.0M	-$6.404B
YoY Change	-1329.79%	134.22%	462.13%
FINANCING ACTIVITIES
Cash Dividend Paid	$578.0M		$1.839B
YoY Change	35.36%		10.02%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00		$1.300B
YoY Change	-100.0%		45.12%
Cash From Financing Activities	-$291.0M	-809.0M	$2.101B
YoY Change	-63.99%	42.67%	-224.11%
NET CHANGE
Cash From Operating Activities	$596.0M	1.508B	$4.421B
Cash From Investing Activities	-$578.0M	-645.0M	-$6.404B
Cash From Financing Activities	-$291.0M	-809.0M	$2.101B
Net Change In Cash	-$273.0M	54.00M	$118.0M
YoY Change	-159.35%	-72.73%	59.81%
FREE CASH FLOW
Cash From Operating Activities	$596.0M	$1.508B	$4.421B
Capital Expenditures	$512.0M	$603.0M	$1.595B
Free Cash Flow	$84.00M	$905.0M	$2.826B
YoY Change	-90.99%	24.93%	65.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Interest Expense InterestExpense	676000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	733000000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	19000000	usd
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	328000000	usd
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	39000000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	8000000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	14000000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	13000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2101000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1693000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146000000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001039684
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsCurrent
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-13643
CY2023	dei	Entity Registrant Name EntityRegistrantName	ONEOK, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OK
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	73-1520922
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 West Fifth Street,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tulsa,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	OK
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	74103
CY2023	dei	City Area Code CityAreaCode	918
CY2023	dei	Local Phone Number LocalPhoneNumber	588-7000
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value of $0.01
CY2023	dei	Trading Symbol TradingSymbol	OKE
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	27400000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	583159446	shares
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Tulsa, Oklahoma
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17677000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22387000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16540000000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	11929000000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	17910000000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	12257000000	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1319000000	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	958000000	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	900000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	626000000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	622000000	usd
CY2021	us-gaap	Taxes Other TaxesOther	167000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	866000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3497000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2250000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	838000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	528000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2659000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1722000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1500000000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000000	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2658000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1721000000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1499000000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.49
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.85
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.36
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.48
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.35
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	484300000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	447500000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	446400000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	485400000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	448400000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	447400000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	2659000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1722000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1500000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-46000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-28000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	61000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	155000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	93000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-204000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	21000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	-60000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	-69000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	66000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-201000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	925000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1564000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-229000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	2000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-16000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-15000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	9000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-53000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-50000000	usd
CY2023	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsTax	1000000	usd
CY2022	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsTax	-5000000	usd
CY2021	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsTax	-1000000	usd
CY2023	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Netof Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsNetofTax	-5000000	usd
CY2022	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Netof Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsNetofTax	16000000	usd
CY2021	oke	Other Comprehensive Income Loss Portion Attributableto Equity Method Investments Netof Tax OtherComprehensiveIncomeLossPortionAttributabletoEquityMethodInvestmentsNetofTax	5000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	75000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	363000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	80000000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2734000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2085000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1580000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	338000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220000000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1705000000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1532000000	usd
CY2023Q4	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	148000000	usd
CY2022Q4	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	149000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	639000000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	432000000	usd
CY2023Q4	oke	Commodity Exchanges And Imbalances CommodityExchangesAndImbalances	26000000	usd
CY2022Q4	oke	Commodity Exchanges And Imbalances CommodityExchangesAndImbalances	43000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	252000000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	172000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3108000000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2548000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	38454000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25015000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5757000000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5063000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32697000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19952000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1874000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	802000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4952000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	528000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1316000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	225000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	319000000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	324000000	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	8461000000	usd
CY2022Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	1879000000	usd
CY2023Q4	us-gaap	Assets Assets	44266000000	usd
CY2022Q4	us-gaap	Assets Assets	24379000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	484000000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1359000000	usd
CY2023Q4	oke	Commodity Exchanges And Imbalances Liabilities Current CommodityExchangesAndImbalancesLiabilitiesCurrent	244000000	usd
CY2022Q4	oke	Commodity Exchanges And Imbalances Liabilities Current CommodityExchangesAndImbalancesLiabilitiesCurrent	254000000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	215000000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	136000000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	381000000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	233000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	541000000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	132000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3452000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3051000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21183000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12696000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2594000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1739000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	479000000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	331000000	usd
CY2023Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	3147000000	usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	2138000000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	609713834	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583093100	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	474916234	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	447157771	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6000000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16320000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7253000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-108000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	868000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	50000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26620734	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	27758463	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	677000000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	706000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16484000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6494000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44266000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24379000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2659000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1722000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1500000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	769000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	626000000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	622000000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	202000000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	148000000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	122000000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	202000000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	147000000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	123000000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	829000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	464000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	472000000	usd
CY2023	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	779000000	usd
CY2022	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	0	usd
CY2021	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	0	usd
CY2023	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	502000000	usd
CY2022	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	61000000	usd
CY2021	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	0	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	83000000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	92000000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	94000000	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-107000000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	148000000	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	611000000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-118000000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	62000000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	105000000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62000000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-26000000	usd
CY2023	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	-96000000	usd
CY2022	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	-197000000	usd
CY2021	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	94000000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	697000000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	207000000	usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3000000	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1000000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	50000000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	20000000	usd
CY2021	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-35000000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-7000000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-14000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6404000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1139000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-665000000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	1839000000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	1672000000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	1667000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5298000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	869000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1300000000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	896000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	605000000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	71000000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	13000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2259000000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	118000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	74000000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-378000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	524000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	338000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146000000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	653000000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	582000000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	692000000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	59000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9000000	usd
CY2021	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	55.00
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.74
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.82
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6043000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1500000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	80000000	usd
CY2021	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	55.00
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	39000000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.74
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	1667000000	usd
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	-22000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6016000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1722000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	363000000	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	55.00
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	39000000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.74
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	1671000000	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	-26000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6494000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2659000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	75000000	usd
CY2023	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	55.00
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	9062000000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	38000000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.82
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	1839000000	usd
CY2023	us-gaap	Stockholders Equity Other StockholdersEquityOther	4000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16484000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of our Consolidated Financial Statements and related disclosures in accordance with GAAP requires us to make estimates and assumptions with respect to values or conditions that cannot be known with certainty that affect the reported amounts on our Consolidated Financial Statements. Items that may be estimated include, but are not limited to, the economic useful life of assets, fair value of assets, liabilities and equity-method investments, obligations under employee benefit plans, allowance for credit losses, expenses for services received but for which no invoice has been received, provision for income taxes, including any deferred tax valuation allowances, the results of litigation and various other recorded or disclosed amounts. In addition, a portion of our revenues and cost of sales and fuel are recorded based on current month prices and estimated volumes. The estimates are reversed in the following month when we record actual volumes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our estimates on an ongoing basis using historical experience, consultation with experts and other methods we consider reasonable based on the particular circumstances. Nevertheless, actual results may differ significantly from the estimates. Any effects on our financial position or results of operations from revisions to these estimates are recorded in the period when the facts that give rise to the revision become known.</span></div>
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We utilize derivatives to reduce our market-risk exposure to commodity price and interest-rate fluctuations and to achieve more predictable cash flows. We record all derivative instruments at fair value, with the exception of normal purchases and normal sales transactions that are expected to result in physical delivery. Commodity price and interest-rate volatility may have a significant impact on the fair value of derivative instruments as of a given date. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding it. The table below summarizes the various ways in which we account for our derivative instruments and the impact on our Consolidated Financial Statements:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Recognition and Measurement</span></td></tr><tr><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounting Treatment</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Normal purchases and<br/>normal sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value not recorded</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value not recognized in earnings</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded at fair value</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gain or loss on the<br/>derivative instrument is reported initially as a<br/>component of accumulated other<br/>comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gain or loss on the derivative instrument is reclassified out of accumulated other comprehensive income (loss) into earnings when the forecasted transaction affects earnings</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value hedge</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recorded at fair value</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gain or loss on the derivative instrument is<br/>recognized in earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value of the hedged item is<br/>recorded as an adjustment to book value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value of the hedged item is<br/>recognized in earnings</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce our exposure to fluctuations in natural gas, NGLs, Refined Products, condensate and crude oil prices, we periodically enter into futures, forward purchases and sales, options or swap transactions in order to hedge anticipated purchases and sales of natural gas, NGLs, Refined Products, condensate and crude oil. Treasury locks and interest-rate swaps are used from time to time to manage interest-rate risk. Under certain conditions, we designate our derivative instruments as a hedge of exposure to changes in fair values or cash flows. We formally document all relationships between hedging instruments and hedged items, as well as risk-management objectives and strategies for undertaking various hedge transactions, and methods for assessing and testing correlation and hedge effectiveness. We specifically identify the forecasted transaction that has been designated as the hedged item in a cash flow hedge relationship. We assess hedging relationships at the inception of the hedge, and periodically thereafter, to determine whether the hedging relationship is, and is expected to remain, highly effective. We also document our normal purchases and normal sales transactions that we expect to result in physical delivery and that we elect to exempt from derivative accounting treatment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realized revenues and purchase costs of our derivative instruments not considered held for trading purposes and derivatives that qualify as normal purchases or normal sales that are expected to result in physical delivery are reported on a gross basis. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from futures, forwards, options and swaps that are accounted for as hedges are included in the same category as the cash flows from the related hedged items in our Consolidated Statements of Cash Flows.</span></div>
CY2023	oke	Number Of Years Of Service Employees Must Work To Be Entitled To Postretirement Medical And Life Insurance Benefits NumberOfYearsOfServiceEmployeesMustWorkToBeEntitledToPostretirementMedicalAndLifeInsuranceBenefits	P5Y
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2023	oke	Additional Adjusted Ebitda AdditionalAdjustedEBITDA	62000000	usd
CY2023Q3	oke	Number Of Unconsolidated Affiliates NumberOfUnconsolidatedAffiliates	8	unconsolidatedaffiliate
CY2023Q4	oke	Derivative Collateral Rightto Reclaim Cash Total DerivativeCollateralRighttoReclaimCashTotal	-41000000	usd
CY2022Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2022Q4	oke	Derivative Collateral Rightto Reclaim Cash Total DerivativeCollateralRighttoReclaimCashTotal	9000000	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	0	usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	-114000000	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	0	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	100000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	-49000000	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	0	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	56000000	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	0	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss	7000000	usd
CY2023Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	0	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	0	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	21400000000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	12700000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	21700000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	13600000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	177000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	84000000	usd
CY2023Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	31000000	usd
CY2022Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	-58000000	usd
CY2023Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	31000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4952000000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33000000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10000000	usd
CY2023Q4	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	38454000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25015000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5757000000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5063000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32697000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19952000000	usd
CY2023	us-gaap	Depreciation Depreciation	736000000	usd
CY2022	us-gaap	Depreciation Depreciation	615000000	usd
CY2023	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	242000000	usd
CY2022	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	171000000	usd
CY2021	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	131000000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	681000000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	153000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	528000000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4424000000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	60000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	60000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	60000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	60000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	60000000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1505000000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	381000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	189000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	156000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1316000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	225000000	usd
CY2023Q4	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2022Q4	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	22794000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13731000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1015000000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	35000000	usd
CY2023Q4	oke	Unamortized Portion Of Debt Issuance Costs And Terminated Swaps UnamortizedPortionOfDebtIssuanceCostsAndTerminatedSwaps	112000000	usd
CY2022Q4	oke	Unamortized Portion Of Debt Issuance Costs And Terminated Swaps UnamortizedPortionOfDebtIssuanceCostsAndTerminatedSwaps	75000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	484000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	925000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21183000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12696000000	usd
CY2021	oke	Longterm Debt Repurchased Face Amount LongtermDebtRepurchasedFaceAmount	55000000	usd
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	55000000	usd
CY2023Q4	oke	Total Aggregate Maturities Of Long Term Debt Outstanding And Interest Obligations On Debt Year One TotalAggregateMaturitiesOfLongTermDebtOutstandingAndInterestObligationsOnDebtYearOne	1651000000	usd
CY2023Q4	oke	Total Aggregate Maturities Of Long Term Debt Outstanding And Interest Obligations On Debt Year Two TotalAggregateMaturitiesOfLongTermDebtOutstandingAndInterestObligationsOnDebtYearTwo	2381000000	usd
CY2023Q4	oke	Total Aggregate Maturities Of Long Term Debt Outstanding And Interest Obligations On Debt Year Three TotalAggregateMaturitiesOfLongTermDebtOutstandingAndInterestObligationsOnDebtYearThree	3098000000	usd
CY2023Q4	oke	Total Aggregate Maturities Of Long Term Debt Outstanding And Interest Obligations On Debt Year Four TotalAggregateMaturitiesOfLongTermDebtOutstandingAndInterestObligationsOnDebtYearFour	1487000000	usd
CY2023Q4	oke	Total Aggregate Maturities Of Long Term Debt Outstanding And Interest Obligations On Debt Year Five TotalAggregateMaturitiesOfLongTermDebtOutstandingAndInterestObligationsOnDebtYearFive	2601000000	usd
CY2023	oke	Aggregate Amount Of Common Shares Available For Issuance And Sale Under Equity Distribution Agreement AggregateAmountOfCommonSharesAvailableForIssuanceAndSaleUnderEquityDistributionAgreement	1000000000	usd
CY2023	us-gaap	Dividends Cash DividendsCash	1800000000	usd
CY2022	us-gaap	Dividends Cash DividendsCash	1700000000	usd
CY2021	us-gaap	Dividends Cash DividendsCash	1700000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.955
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.955
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.955
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.955
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.935
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.82
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.74
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.74
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1100000	usd
CY2023	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1100000	usd
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1100000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2658000000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	484300000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.49
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1100000	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2658000000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	485400000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.48
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1721000000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	447500000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.85
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	900000	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1721000000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	448400000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1499000000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	446400000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.36
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000.0	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1499000000	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	447400000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.35
CY2023Q4	oke	Forfeiture Rate Maximum In Hundredths ForfeitureRateMaximumInHundredths	0.03	rate
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	13000000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14000000	usd
CY2023Q4	oke	Duration Of Historical Volatility DurationOfHistoricalVolatility	P3Y
CY2023Q4	oke	Number Of Defined Benefit Pension Plans NumberOfDefinedBenefitPensionPlans	2	pensionplan
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-64000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	48000000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-3000000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	52000000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12000000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12000000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9000000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9000000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	64000000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12000000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	739000000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	423000000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	433000000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	90000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	41000000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	39000000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	829000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	464000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	472000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	838000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	528000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3497000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2250000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1984000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	rate
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	rate
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	rate
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	734000000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	472000000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	417000000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	100000000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	54000000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	40000000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2000000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1000000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	6000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1000000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-2000000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1000000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	23000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	838000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	528000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484000000	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	19000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	88000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	82000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2534000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1105000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	492000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	196000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	19000000	usd
CY2023Q4	oke	Deferred Tax Assets Interest Expense Limitations DeferredTaxAssetsInterestExpenseLimitations	210000000	usd
CY2022Q4	oke	Deferred Tax Assets Interest Expense Limitations DeferredTaxAssetsInterestExpenseLimitations	25000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3344000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1432000000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	240000000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	75000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3104000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1357000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	104000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	95000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	7000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	5587000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	3001000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5698000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3096000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2594000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1739000000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	165000000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6000000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1000000	usd
CY2023Q3	oke	Number Of Unconsolidated Affiliates NumberOfUnconsolidatedAffiliates	8	unconsolidatedaffiliate
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1874000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	802000000	usd
CY2023Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	148000000	usd
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	17000000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	202000000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	148000000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	122000000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	132000000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	83000000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	63000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	145000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	117000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	83000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	68000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	64000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	277000000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	754000000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	51000000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36000000	usd
CY2022	oke	Contractwith Customer Liability Net Additions ContractwithCustomerLiabilityNetAdditions	37000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	52000000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	23000000	usd
CY2023	oke	Contractwith Customer Liability Net Additions ContractwithCustomerLiabilityNetAdditions	121000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	150000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	29000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	104000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	46000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1174000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	920000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	764000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	671000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1912000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5441000000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17677000000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	11929000000	usd
CY2023	us-gaap	Direct Operating Costs DirectOperatingCosts	1535000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	769000000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	202000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1874000000	usd
CY2023Q4	us-gaap	Assets Assets	44266000000	usd
CY2023	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	1595000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22387000000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	17910000000	usd
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	1149000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	626000000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	148000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	802000000	usd
CY2022Q4	us-gaap	Assets Assets	24379000000	usd
CY2022	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	1202000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16540000000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	12257000000	usd
CY2021	us-gaap	Direct Operating Costs DirectOperatingCosts	1067000000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	622000000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	122000000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	798000000	usd
CY2021Q4	us-gaap	Assets Assets	23622000000	usd
CY2021	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	697000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2659000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1722000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1500000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	866000000	usd
CY2022	us-gaap	Interest Expense InterestExpense	676000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	733000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	769000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	626000000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	622000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	838000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	528000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484000000	usd
CY2023	oke	Adjusted Ebitda Unconsolidated Affiliates AdjustedEBITDAUnconsolidatedAffiliates	264000000	usd
CY2022	oke	Adjusted Ebitda Unconsolidated Affiliates AdjustedEBITDAUnconsolidatedAffiliates	0	usd
CY2021	oke	Adjusted Ebitda Unconsolidated Affiliates AdjustedEBITDAUnconsolidatedAffiliates	0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	202000000	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	49000000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	68000000	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	41000000	usd
CY2023	oke	Other Corporate Costsand Noncash Items OtherCorporateCostsandNoncashItems	70000000	usd
CY2022	oke	Other Corporate Costsand Noncash Items OtherCorporateCostsandNoncashItems	0	usd
CY2021	oke	Other Corporate Costsand Noncash Items OtherCorporateCostsandNoncashItems	1000000	usd
CY2023	oke	Adjusted Ebitda AdjustedEBITDA	5313000000	usd
CY2022	oke	Adjusted Ebitda AdjustedEBITDA	3620000000	usd
CY2021	oke	Adjusted Ebitda AdjustedEBITDA	3381000000	usd
CY2023	oke	Additional Adjusted Ebitda AdditionalAdjustedEBITDA	62000000	usd
CY2023	dei	Auditor Firm AuditorFirmId	238

Files In Submission

Name	View Source	Status
0001039684-24-000015-index-headers.html	Edgar Link	pending
0001039684-24-000015-index.html	Edgar Link	pending
0001039684-24-000015.txt	Edgar Link	pending
0001039684-24-000015-xbrl.zip	Edgar Link	pending
exb1024oneokeip-2024rsua.htm	Edgar Link	pending
exb1024oneokeip-2024rsua001.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua002.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua003.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua004.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua005.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua006.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua007.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua008.jpg	Edgar Link	pending
exb1024oneokeip-2024rsua009.jpg	Edgar Link	pending
exb1025oneokeip-2024psua.htm	Edgar Link	pending
exb1025oneokeip-2024psua001.jpg	Edgar Link	pending
exb1025oneokeip-2024psua002.jpg	Edgar Link	pending
exb1025oneokeip-2024psua003.jpg	Edgar Link	pending
exb1025oneokeip-2024psua004.jpg	Edgar Link	pending
exb1025oneokeip-2024psua005.jpg	Edgar Link	pending
exb1025oneokeip-2024psua006.jpg	Edgar Link	pending
exb1025oneokeip-2024psua007.jpg	Edgar Link	pending
exb1025oneokeip-2024psua008.jpg	Edgar Link	pending
exb1025oneokeip-2024psua009.jpg	Edgar Link	pending
exb1025oneokeip-2024psua010.jpg	Edgar Link	pending
exb1025oneokeip-2024psua011.jpg	Edgar Link	pending
exb1025oneokeip-2024psua012.jpg	Edgar Link	pending
exb1025oneokeip-2024psua013.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oke-20231231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
oke-20231231.xsd	Edgar Link	pending
oke-20231231_g1.jpg	Edgar Link	pending
oke-20231231_g2.jpg	Edgar Link	pending
oke-20231231_g3.jpg	Edgar Link	pending
oke-20231231_g4.jpg	Edgar Link	pending
oke-20231231_g5.jpg	Edgar Link	pending
oke-20231231_g6.jpg	Edgar Link	pending
oke-20231231_g7.jpg	Edgar Link	pending
oke-20231231_g8.jpg	Edgar Link	pending
oke10-k2023ex23xpwcconsent.htm	Edgar Link	pending
oke10-k2023exhibit21.htm	Edgar Link	pending
oke10-k2023exhibit221.htm	Edgar Link	pending
oke2023ex97xcompensation.htm	Edgar Link	pending
oke2023ex97xcompensation001.jpg	Edgar Link	pending
oke2023ex97xcompensation002.jpg	Edgar Link	pending
oke2023ex97xcompensation003.jpg	Edgar Link	pending
oke2023ex97xcompensation004.jpg	Edgar Link	pending
oke2023ex97xcompensation005.jpg	Edgar Link	pending
oke2023ex97xcompensation006.jpg	Edgar Link	pending
oke2023ex97xcompensation007.jpg	Edgar Link	pending
oke2023ex97xcompensation008.jpg	Edgar Link	pending
okeq42023exhibit311.htm	Edgar Link	pending
okeq42023exhibit312.htm	Edgar Link	pending
okeq42023exhibit321.htm	Edgar Link	pending
okeq42023exhibit322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
oke-20231231_def.xml	Edgar Link	unprocessable
oke-20231231_lab.xml	Edgar Link	unprocessable
oke-20231231_pre.xml	Edgar Link	unprocessable
oke-20231231_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
oke-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OKE
ONEOK INC /NEW/ Stock $oke

2024 Q1 Form 10-K Financial Statement

#000103968424000015 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OKE ONEOK INC /NEW/ Stock $oke

2024 Q1 Form 10-K Financial Statement

#000103968424000015 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OKE
ONEOK INC /NEW/ Stock $oke